Tag Archives: Katsuhiko Muraki

Naltrexone restores impaired Transient Receptor Potential Melastatin 3 ion channel function in Natural Killer Cells from ME/CFS

Naltrexone restores impaired Transient Receptor Potential Melastatin 3 ion channel function in Natural Killer Cells from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients, by Helene Cabanas,  Katsuhiko Muraki,  Donald Staines and Sonya Marshall-Gradisnik in Front. Immunol., 31 October 2019 [https://doi.org/10.3389/fimmu.2019.02545]   Research … Continue reading

Posted in News | Tagged , , , , , , , , | Comments Off on Naltrexone restores impaired Transient Receptor Potential Melastatin 3 ion channel function in Natural Killer Cells from ME/CFS

Validation of impaired TRPM3 ion channel activity in natural killer cells from CFS/ME

Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients, by H Cabanas, K Muraki, C Balinas, N Eaton-Fitch, D Staines, S Marshall-Gradisnik in Mol Med. 2019 Apr … Continue reading

Posted in News | Tagged , , , , , , , , , | Comments Off on Validation of impaired TRPM3 ion channel activity in natural killer cells from CFS/ME

Loss of transient receptor potential Melastatin 3 ion channel function in natural killer cells from CFS/ME

Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from CFS/ME patients by Hélène Cabanas, Katsuhiko Muraki, Natalie Eaton, Cassandra Balinas, Donald Staines and Sonya Marshall-Gradisnik in Molecular Medicine 2018 24:44 [Published: 14 August 2018] Research abstract: … Continue reading

Posted in News | Tagged , , , , , , , , , , , | Comments Off on Loss of transient receptor potential Melastatin 3 ion channel function in natural killer cells from CFS/ME